Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Seamus Fernandez is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/12/2025 | PCVX | Buy Now | Vaxcyte | $74.31 | 115.31% | Seamus Fernandez61% | $160 → $160 | Reiterates | Buy → Buy | Get Alert |
| 02/26/2025 | PCVX | Buy Now | Vaxcyte | $74.31 | 115.31% | Seamus Fernandez61% | $160 → $160 | Reiterates | Buy → Buy | Get Alert |
| 02/25/2025 | MTSR | Buy Now | Metsera | $30.33 | 84.64% | Seamus Fernandez61% | → $56 | Initiates | → Buy | Get Alert |
| 02/24/2025 | ARQT | Buy Now | Arcutis Biotherapeutics | $15.88 | — | Seamus Fernandez61% | — | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | — | Seamus Fernandez61% | — | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | ARQT | Buy Now | Arcutis Biotherapeutics | $15.88 | — | Seamus Fernandez61% | — | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | APGE | Buy Now | Apogee Therapeutics | $39.01 | — | Seamus Fernandez61% | — | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | APGE | Buy Now | Apogee Therapeutics | $39.01 | — | Seamus Fernandez61% | — | Reiterates | Buy → Buy | Get Alert |
| 12/03/2024 | APGE | Buy Now | Apogee Therapeutics | $39.01 | 181.98% | Seamus Fernandez61% | $95 → $110 | Reiterates | Buy → Buy | Get Alert |
| 11/27/2024 | APGE | Buy Now | Apogee Therapeutics | $39.01 | 181.98% | Seamus Fernandez61% | $95 → $110 | Maintains | Buy | Get Alert |
| 11/08/2024 | CDTX | Buy Now | Cidara Therapeutics | $22.40 | 47.32% | Seamus Fernandez61% | → $33 | Initiates | → Buy | Get Alert |
| 11/06/2024 | MRK | Buy Now | Merck & Co | $94.90 | 36.99% | Seamus Fernandez61% | $137 → $130 | Maintains | Buy | Get Alert |
| 10/31/2024 | GSK | Buy Now | GSK | $40.21 | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/21/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $52.29 | 33.87% | Seamus Fernandez61% | → $70 | Initiates | → Buy | Get Alert |
| 10/14/2024 | TENX | Buy Now | Tenax Therapeutics | $6.10 | 162.3% | Seamus Fernandez61% | → $16 | Initiates | → Buy | Get Alert |
| 10/08/2024 | MBX | Buy Now | MBX Biosciences | $8.42 | 422.57% | Seamus Fernandez61% | → $44 | Initiates | → Buy | Get Alert |
| 08/16/2024 | LLY | Buy Now | Eli Lilly | $821.00 | 25.46% | Seamus Fernandez61% | $884 → $1030 | Maintains | Buy | Get Alert |
| 08/12/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/05/2024 | LLY | Buy Now | Eli Lilly | $821.00 | 7.67% | Seamus Fernandez61% | $855 → $884 | Maintains | Buy | Get Alert |
| 07/08/2024 | HLVX | Buy Now | HilleVax | $1.72 | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/29/2024 | ALT | Buy Now | Altimmune | $5.72 | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/05/2024 | APGE | Buy Now | Apogee Therapeutics | $39.01 | 133.27% | Seamus Fernandez61% | $44 → $91 | Maintains | Buy | Get Alert |
| 03/04/2024 | GSK | Buy Now | GSK | $40.21 | — | Seamus Fernandez61% | — | Upgrade | Neutral → Buy | Get Alert |
| 01/03/2024 | APGE | Buy Now | Apogee Therapeutics | $39.01 | 12.79% | Seamus Fernandez61% | $29 → $44 | Maintains | Buy | Get Alert |
| 01/02/2024 | ICVX | Buy Now | Icosavax | — | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/17/2023 | ICVX | Buy Now | Icosavax | — | — | Seamus Fernandez61% | → $28 | Initiates | → Buy | Get Alert |
| 11/15/2023 | HLVX | Buy Now | HilleVax | $1.72 | 1876.74% | Seamus Fernandez61% | $38 → $34 | Maintains | Buy | Get Alert |
| 08/15/2023 | VERV | Buy Now | Verve Therapeutics | $5.85 | 840.17% | Seamus Fernandez61% | $56 → $55 | Maintains | Buy | Get Alert |
| 08/11/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Seamus Fernandez61% | → $20 | Initiates | → Buy | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $39.01 | -25.66% | Seamus Fernandez61% | → $29 | Initiates | → Buy | Get Alert |
| 07/14/2023 | ARCT | Buy Now | Arcturus Therapeutics | $13.73 | — | Seamus Fernandez61% | — | Maintains | Buy | Get Alert |
| 04/11/2023 | MRK | Buy Now | Merck & Co | $94.90 | 30.66% | Seamus Fernandez61% | $123 → $124 | Maintains | Buy | Get Alert |
| 04/11/2023 | LLY | Buy Now | Eli Lilly | $821.00 | -52.25% | Seamus Fernandez61% | $395 → $392 | Maintains | Buy | Get Alert |
| 03/29/2023 | ARCT | Buy Now | Arcturus Therapeutics | $13.73 | 162.2% | Seamus Fernandez61% | → $36 | Reiterates | → Buy | Get Alert |
| 03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 107.39% | Seamus Fernandez61% | → $32 | Initiates | → Buy | Get Alert |
| 02/28/2023 | PCVX | Buy Now | Vaxcyte | $74.31 | -12.53% | Seamus Fernandez61% | $66 → $65 | Maintains | Buy | Get Alert |
| 02/28/2023 | GPCR | Buy Now | Structure Therapeutics | $21.11 | 136.85% | Seamus Fernandez61% | → $50 | Initiates | → Buy | Get Alert |
| 01/11/2023 | ALBO | Buy Now | Albireo Pharma | — | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/15/2022 | PCVX | Buy Now | Vaxcyte | $74.31 | -11.18% | Seamus Fernandez61% | → $66 | Initiates | → Buy | Get Alert |
| 12/07/2022 | LLY | Buy Now | Eli Lilly | $821.00 | -51.16% | Seamus Fernandez61% | $399 → $401 | Maintains | Buy | Get Alert |
| 11/15/2022 | DICE | Buy Now | DICE Therapeutics | — | — | Seamus Fernandez61% | → $65 | Initiates | → Buy | Get Alert |
| 11/01/2022 | MRK | Buy Now | Merck & Co | $94.90 | 16.97% | Seamus Fernandez61% | $104 → $111 | Maintains | Buy | Get Alert |
| 10/10/2022 | MRK | Buy Now | Merck & Co | $94.90 | — | Seamus Fernandez61% | — | Upgrade | Neutral → Buy | Get Alert |
| 10/10/2022 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/16/2022 | ALT | Buy Now | Altimmune | $5.72 | 354.55% | Seamus Fernandez61% | $31 → $26 | Maintains | Buy | Get Alert |
| 09/08/2022 | ALBO | Buy Now | Albireo Pharma | — | — | Seamus Fernandez61% | → $55 | Initiates | → Buy | Get Alert |
| 05/31/2022 | NVO | Buy Now | Novo Nordisk | $81.09 | — | Seamus Fernandez61% | — | Upgrade | Neutral → Buy | Get Alert |
| 05/24/2022 | HLVX | Buy Now | HilleVax | $1.72 | 2225.58% | Seamus Fernandez61% | → $40 | Initiates | → Buy | Get Alert |
| 12/15/2021 | ADGI | Buy Now | Adagio Therapeutics | — | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/07/2021 | MRK | Buy Now | Merck & Co | $94.90 | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/31/2021 | ADGI | Buy Now | Adagio Therapeutics | — | — | Seamus Fernandez61% | → $40 | Initiates | → Buy | Get Alert |
| 02/11/2021 | ALT | Buy Now | Altimmune | $5.72 | 529.38% | Seamus Fernandez61% | → $36 | Initiates | → Buy | Get Alert |
| 10/19/2020 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 16.67% | Seamus Fernandez61% | → $70 | Upgrade | Neutral → Buy | Get Alert |
| 04/29/2020 | MRK | Buy Now | Merck & Co | $94.90 | -2% | Seamus Fernandez61% | $101 → $93 | Maintains | Buy | Get Alert |
| 02/25/2020 | NVS | Buy Now | Novartis | $112.22 | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/03/2020 | DERM | Buy Now | Journey Medical | $5.29 | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/03/2020 | NVO | Buy Now | Novo Nordisk | $81.09 | — | Seamus Fernandez61% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/25/2019 | NVS | Buy Now | Novartis | $112.22 | — | Seamus Fernandez61% | — | Upgrade | Neutral → Buy | Get Alert |
| 12/04/2018 | TSRO | Buy Now | Tesaro | — | — | Seamus Fernandez61% | $48 → $75 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/15/2018 | ITCI | Buy Now | Intra-Cellular Therapies | $131.45 | -79.46% | Seamus Fernandez61% | → $27 | Initiates | → Outperform | Get Alert |
| 11/13/2018 | AGN | Buy Now | Allergan | — | — | Seamus Fernandez61% | → $220 | Initiates | → Outperform | Get Alert |
| 11/13/2018 | ITCI | Buy Now | Intra-Cellular Therapies | $131.45 | -79.46% | Seamus Fernandez61% | → $27 | Initiates | → Outperform | Get Alert |
| 09/25/2018 | TSRO | Buy Now | Tesaro | — | — | Seamus Fernandez61% | → $48 | Initiates | → Outperform | Get Alert |
| 03/13/2018 | ACRS | Buy Now | Aclaris Therapeutics | $1.58 | 3317.72% | Seamus Fernandez61% | $56 → $54 | Maintains | Outperform | Get Alert |
| 03/08/2018 | CLDX | Buy Now | Celldex Therapeutics | $19.89 | -84.92% | Seamus Fernandez61% | $60 → $45 | Maintains | Market Perform | Get Alert |
| 02/07/2018 | AGN | Buy Now | Allergan | — | — | Seamus Fernandez61% | $237 → $242 | Maintains | Outperform | Get Alert |
| 02/06/2018 | MRK | Buy Now | Merck & Co | $94.90 | -29.4% | Seamus Fernandez61% | $69 → $67 | Maintains | Market Perform | Get Alert |
| 02/06/2018 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 26.67% | Seamus Fernandez61% | $71 → $76 | Maintains | Outperform | Get Alert |
| 02/06/2018 | AZN | Buy Now | AstraZeneca | $77.37 | -50.89% | Seamus Fernandez61% | $36 → $38 | Maintains | Market Perform | Get Alert |
| 01/31/2018 | PFE | Buy Now | Pfizer | $26.30 | 44.48% | Seamus Fernandez61% | $35 → $38 | Maintains | Market Perform | Get Alert |
| 01/25/2018 | NVS | Buy Now | Novartis | $112.22 | -10.89% | Seamus Fernandez61% | $91 → $100 | Maintains | Market Perform | Get Alert |
| 11/27/2017 | AGN | Buy Now | Allergan | — | — | Seamus Fernandez61% | → $237 | Reinstates | Outperform → Outperform | Get Alert |
| 11/15/2017 | TSRO | Buy Now | Tesaro | — | — | Seamus Fernandez61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/30/2017 | MRK | Buy Now | Merck & Co | $94.90 | -27.29% | Seamus Fernandez61% | $70 → $69 | Maintains | Market Perform | Get Alert |
| 10/23/2017 | NVS | Buy Now | Novartis | $112.22 | -18.91% | Seamus Fernandez61% | $89 → $91 | Maintains | Market Perform | Get Alert |
| 10/23/2017 | MRK | Buy Now | Merck & Co | $94.90 | -26.24% | Seamus Fernandez61% | $69 → $70 | Maintains | Market Perform | Get Alert |
| 10/23/2017 | LLY | Buy Now | Eli Lilly | $821.00 | -88.67% | Seamus Fernandez61% | $92 → $93 | Maintains | Market Perform | Get Alert |
| 10/23/2017 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 20% | Seamus Fernandez61% | $61 → $72 | Maintains | Outperform | Get Alert |
| 10/23/2017 | AZN | Buy Now | AstraZeneca | $77.37 | -56.06% | Seamus Fernandez61% | $31 → $34 | Maintains | Market Perform | Get Alert |
| 07/28/2017 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 1.67% | Seamus Fernandez61% | $66 → $61 | Maintains | Outperform | Get Alert |
| 07/27/2017 | AZN | Buy Now | AstraZeneca | $77.37 | — | Seamus Fernandez61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/26/2017 | LLY | Buy Now | Eli Lilly | $821.00 | — | Seamus Fernandez61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/02/2017 | ITCI | Buy Now | Intra-Cellular Therapies | $131.45 | — | Seamus Fernandez61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/10/2017 | TSRO | Buy Now | Tesaro | — | — | Seamus Fernandez61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/12/2017 | MRK | Buy Now | Merck & Co | $94.90 | -26.24% | Seamus Fernandez61% | → $70 | Upgrade | Neutral → Buy | Get Alert |
| 12/09/2016 | AZN | Buy Now | AstraZeneca | $77.37 | — | Seamus Fernandez61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/10/2016 | TSRO | Buy Now | Tesaro | — | — | Seamus Fernandez61% | — | Maintains | Outperform | Get Alert |
| 05/05/2016 | PFE | Buy Now | Pfizer | $26.30 | 34.97% | Seamus Fernandez61% | $34.7 → $35.5 | Maintains | Market Perform | Get Alert |
| 05/02/2016 | AZN | Buy Now | AstraZeneca | $77.37 | -56.06% | Seamus Fernandez61% | $38 → $34 | Maintains | Market Perform | Get Alert |
| 05/02/2016 | PFE | Buy Now | Pfizer | $26.30 | 31.93% | Seamus Fernandez61% | $37 → $34.7 | Maintains | Market Perform | Get Alert |
| 05/02/2016 | LLY | Buy Now | Eli Lilly | $821.00 | -87.7% | Seamus Fernandez61% | $96 → $101 | Maintains | Outperform | Get Alert |
| 03/23/2016 | NVS | Buy Now | Novartis | $112.22 | -24.26% | Seamus Fernandez61% | $98 → $85 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/07/2016 | CLDX | Buy Now | Celldex Therapeutics | $19.89 | -79.89% | Seamus Fernandez61% | $450 → $60 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/28/2015 | LLY | Buy Now | Eli Lilly | $821.00 | -88.43% | Seamus Fernandez61% | $93 → $95 | Maintains | Outperform | Get Alert |
| 12/02/2015 | AGN | Buy Now | Allergan | — | — | Seamus Fernandez61% | $355 → $393 | Maintains | Outperform | Get Alert |
| 12/02/2015 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | — | Seamus Fernandez61% | — | Upgrade | Neutral → Buy | Get Alert |
| 11/05/2015 | AGN | Buy Now | Allergan | — | — | Seamus Fernandez61% | $342 → $355 | Maintains | Outperform | Get Alert |
| 10/28/2015 | AGN | Buy Now | Allergan | — | — | Seamus Fernandez61% | $311 → $342 | Maintains | Outperform | Get Alert |
| 10/13/2015 | LLY | Buy Now | Eli Lilly | $821.00 | -89.04% | Seamus Fernandez61% | $93 → $90 | Maintains | Outperform | Get Alert |
| 07/27/2015 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 28.33% | Seamus Fernandez61% | $76 → $77 | Maintains | Outperform | Get Alert |
| 07/27/2015 | NVS | Buy Now | Novartis | $112.22 | -1.98% | Seamus Fernandez61% | $107 → $110 | Maintains | Outperform | Get Alert |
| 07/27/2015 | LLY | Buy Now | Eli Lilly | $821.00 | -88.67% | Seamus Fernandez61% | $92 → $93 | Maintains | Outperform | Get Alert |
| 06/26/2015 | LLY | Buy Now | Eli Lilly | $821.00 | -88.79% | Seamus Fernandez61% | $77 → $92 | Maintains | Outperform | Get Alert |
| 03/16/2015 | MRK | Buy Now | Merck & Co | $94.90 | -34.14% | Seamus Fernandez61% | $66 → $62.5 | Maintains | Market Perform | Get Alert |
| 03/13/2015 | LLY | Buy Now | Eli Lilly | $821.00 | -90.62% | Seamus Fernandez61% | $75 → $77 | Maintains | Outperform | Get Alert |
| 03/12/2015 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 22.5% | Seamus Fernandez61% | $72 → $73.5 | Maintains | Outperform | Get Alert |
| 01/22/2015 | AZN | Buy Now | AstraZeneca | $77.37 | -0.48% | Seamus Fernandez61% | $76 → $77 | Maintains | Market Perform | Get Alert |
| 10/02/2014 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | -5% | Seamus Fernandez61% | → $57 | Initiates | → Neutral | Get Alert |
| 10/02/2014 | MRK | Buy Now | Merck & Co | $94.90 | -31.51% | Seamus Fernandez61% | → $65 | Initiates | → Neutral | Get Alert |
| 08/13/2014 | ITCI | Buy Now | Intra-Cellular Therapies Inc. | $131.45 | -73.37% | Seamus Fernandez61% | $34 → $35 | Maintains | Outperform | Get Alert |
| 08/08/2014 | AGN | Buy Now | Allergan | — | — | Seamus Fernandez61% | → $184 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/15/2014 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 3.33% | Seamus Fernandez61% | → $62 | Maintains | Outperform | Get Alert |
| 04/28/2014 | LLY | Buy Now | Eli Lilly | $821.00 | -91.96% | Seamus Fernandez61% | $61 → $66 | Maintains | Outperform | Get Alert |
| 06/24/2013 | AGN | Buy Now | Allergan | — | — | Seamus Fernandez61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/16/2013 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | — | Seamus Fernandez61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 03/06/2013 | CLDX | Buy Now | Celldex Therapeutics | $19.89 | — | Seamus Fernandez61% | — | Initiates | → Outperform | Get Alert |
| 02/04/2013 | MRK | Buy Now | Merck & Co | $94.90 | — | Seamus Fernandez61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/15/2012 | LLY | Buy Now | Eli Lilly | $821.00 | — | Seamus Fernandez61% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 08/02/2012 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | — | Seamus Fernandez61% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/23/2012 | TSRO | Buy Now | Tesaro | — | — | Seamus Fernandez61% | — | Initiates | → Outperform | Get Alert |
